Structure-activity analysis of peptidic Chlamydia HtrA inhibitors
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 27 (18) , 4185-4199
Abstract
No abstract availableKeywords
Funding Information
- Otago Medical Research Foundation
This publication has 36 references indexed in Scilit:
- Azithromycin antimicrobial resistance and genitalChlamydia trachomatisinfection: duration of therapy may be the key to improving efficacySexually Transmitted Infections, 2012
- Unique Residues Involved in Activation of the Multitasking Protease/Chaperone HtrA from Chlamydia trachomatisPLOS ONE, 2011
- Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human DiseasesPharmacological Reviews, 2010
- Antibiotic Resistance in ChlamydiaeFuture Microbiology, 2010
- Determinants of structural and functional plasticity of a widely conserved protease chaperone complexNature Structural & Molecular Biology, 2010
- The epimerization of peptide aldehydes—a systematic studyJournal of Peptide Science, 2006
- α-Ketoamides, α-ketoesters and α-diketones as HCV NS3 protease inhibitorsBioorganic & Medicinal Chemistry Letters, 2000
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Peptidyl .alpha.-ketoheterocyclic inhibitors of human neutrophil elastase. 2. Effect of varying the heterocyclic ring on in vitro potencyJournal of Medicinal Chemistry, 1995
- Intermolecular pinacol cross coupling of electronically similar aldehydes. An efficient and stereoselective synthesis of 1,2-diols employing a practical vanadium(II) reagentJournal of the American Chemical Society, 1989